Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation. 2012

Hiroya Iida, and Tsukasa Aihara, and Shinichi Ikuta, and Hidenori Yoshie, and Naoki Yamanaka
Department of Surgery, Meiwa Hospital 4-31 Agenaruo-cho, Nisinomiya, Hyogo 663-8186, Japan. hiroya0001@mac.com

OBJECTIVE To compare the effect of percutaneous transhepatic portal vein embolization (PTPE) and unilateral portal vein ligation (PVL) on hepatic hemodynamics and right hepatic lobe (RHL) atrophy. METHODS Between March 2005 and March 2009, 13 cases were selected for PTPE (n = 9) and PVL (n = 4) in the RHL. The PTPE group included hilar bile duct carcinoma (n = 2), intrahepatic cholangiocarcinoma (n = 2), hepatocellular carcinoma (n = 2) and liver metastasis (n = 3). The PVL group included hepatocellular carcinoma (n = 2) and liver metastasis (n = 2). In addition, observation of postoperative hepatic hemodynamics obtained from computed tomography and Doppler ultrasonography was compared between the two groups. RESULTS Mean ages in the two groups were 58.9 ± 2.9 years (PVL group) vs 69.7 ± 3.2 years (PTPE group), which was a significant difference (P = 0.0002). Among the indicators of liver function, including serum albumin, serum bilirubin, aspartate aminotransferase, alanine aminotransferase, platelets and indocyanine green retention rate at 15 min, no significant differences were observed between the two groups. Preoperative RHL volumes in the PTPE and PVL groups were estimated to be 804.9 ± 181.1 mL and 813.3 ± 129.7 mL, respectively, with volume rates of 68.9% ± 2.8% and 69.2% ± 4.2%, respectively. There were no significant differences in RHL volumes (P = 0.83) and RHL volume rates (P = 0.94), respectively. At 1 mo after PTPE or PVL, postoperative RHL volumes in the PTPE and PVL groups were estimated to be 638.4 ± 153.6 mL and 749.8 ± 121.9 mL, respectively, with no significant difference (P = 0.14). Postoperative RHL volume rates in the PTPE and PVL groups were estimated to be 54.6% ± 4.2% and 63.7% ± 3.9%, respectively, which was a significant difference (P = 0.0056). At 1 mo after the operation, the liver volume atrophy rate was 14.3% ± 2.3% in the PTPE group and 5.4% ± 1.6% in the PVL group, which was a significant difference (P = 0.0061). CONCLUSIONS PTPE is a more effective procedure than PVL because PTPE is able to occlude completely the portal branch throughout the right peripheral vein.

UI MeSH Term Description Entries
D008026 Ligation Application of a ligature to tie a vessel or strangulate a part. Ligature,Ligations,Ligatures
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008102 Liver Circulation The circulation of BLOOD through the LIVER. Hepatic Circulation,Circulation, Liver,Circulation, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D004621 Embolization, Therapeutic A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Embolotherapy,Therapeutic Embolization,Embolizations, Therapeutic,Embolotherapies,Therapeutic Embolizations

Related Publications

Hiroya Iida, and Tsukasa Aihara, and Shinichi Ikuta, and Hidenori Yoshie, and Naoki Yamanaka
December 2002, Journal of vascular and interventional radiology : JVIR,
Hiroya Iida, and Tsukasa Aihara, and Shinichi Ikuta, and Hidenori Yoshie, and Naoki Yamanaka
April 1998, Nihon Geka Gakkai zasshi,
Hiroya Iida, and Tsukasa Aihara, and Shinichi Ikuta, and Hidenori Yoshie, and Naoki Yamanaka
June 2008, Seminars in interventional radiology,
Hiroya Iida, and Tsukasa Aihara, and Shinichi Ikuta, and Hidenori Yoshie, and Naoki Yamanaka
April 2012, AJR. American journal of roentgenology,
Hiroya Iida, and Tsukasa Aihara, and Shinichi Ikuta, and Hidenori Yoshie, and Naoki Yamanaka
June 2004, Nihon Geka Gakkai zasshi,
Hiroya Iida, and Tsukasa Aihara, and Shinichi Ikuta, and Hidenori Yoshie, and Naoki Yamanaka
August 1998, Annals of surgery,
Hiroya Iida, and Tsukasa Aihara, and Shinichi Ikuta, and Hidenori Yoshie, and Naoki Yamanaka
March 2024, Interventional radiology (Higashimatsuyama-shi (Japan),
Hiroya Iida, and Tsukasa Aihara, and Shinichi Ikuta, and Hidenori Yoshie, and Naoki Yamanaka
April 2015, Journal of hepato-biliary-pancreatic sciences,
Hiroya Iida, and Tsukasa Aihara, and Shinichi Ikuta, and Hidenori Yoshie, and Naoki Yamanaka
April 2018, Acta radiologica open,
Hiroya Iida, and Tsukasa Aihara, and Shinichi Ikuta, and Hidenori Yoshie, and Naoki Yamanaka
August 1989, Rinsho hoshasen. Clinical radiography,
Copied contents to your clipboard!